These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30909)

  • 1. Recent physiochemical and quantum chemical studies on drugs of abuse and relevant biomolecules.
    Kaufman JJ
    NIDA Res Monogr; 1978; (22):250-77. PubMed ID: 30909
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiocochemical, quantum chemical, and other theoretical techniques for the understanding of the pharmacologic action of drugs that affect the central nervous system: psychotropic drugs, narcotics, and narcotic antagonists and anesthetics.
    Kaufman JJ
    Cancer Chemother Rep 2; 1974 Dec; 4(4):49-50. PubMed ID: 4447934
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonists.
    Katz R; Osborne S; Ionescu F; Andrulis P; Bates R; Beavers W; Chou PC; Loew G; Berkowitz D
    NIDA Res Monogr; 1978; (22):441-63. PubMed ID: 30912
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
    Loew GH; Berkowitz DS; Burt SK
    NIDA Res Monogr; 1978; (22):278-316. PubMed ID: 213725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational energies and geometries of narcotics, using a potential function method.
    Froimowitz M
    NIDA Res Monogr; 1978; (22):359-73. PubMed ID: 30910
    [No Abstract]   [Full Text] [Related]  

  • 6. Narcotic and narcotic antagonist pKa's and partition coefficients and their significance in clinical practice.
    Kaufmann JJ; Koski WS; Benson DN; Semo NM
    Drug Alcohol Depend; 1975 Dec; 1(2):103-14. PubMed ID: 13983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral methods for the study of drug interactions.
    Schuster CR
    Ann N Y Acad Sci; 1976; 281():64-73. PubMed ID: 828471
    [No Abstract]   [Full Text] [Related]  

  • 8. A proposed mode of action for narcotic agonists and antagonists.
    Cho TM; Law PY; Loh HH
    Adv Biochem Psychopharmacol; 1979; 20():69-101. PubMed ID: 224664
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantum chemical studies of molecular features and receptor interactions that modulate opiate agonist and antagonist activity.
    Burt SK; Loew GH; Hashimoto GM
    Ann N Y Acad Sci; 1981; 367():219-39. PubMed ID: 6266317
    [No Abstract]   [Full Text] [Related]  

  • 10. A brief overview of the clinical pharmacology of "club drugs".
    Britt GC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of emerging and new psychoactive substances in the United Kingdom.
    Beharry S; Gibbons S
    Forensic Sci Int; 2016 Oct; 267():25-34. PubMed ID: 27552699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theoretical aspects of the quantitative study of the chemical structure-biological action relationship].
    Danchev D; Staneva D; Mikhaĭlova D; Nacheva R
    Eksp Med Morfol; 1979; 18(2):61-8. PubMed ID: 380967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidosis lowers in-vivo potency of narcotics and narcotic antagonists and can even abolish narcotic antagonist activity.
    Kaufman JJ
    Lancet; 1982 Mar; 1(8271):559-60. PubMed ID: 6120409
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of quantum mechanical techniques for use in structure activity relationship development, and application to analgesics and other drugs.
    Cheney BV; Duchamp DJ; Christoffersen RE
    NIDA Res Monogr; 1978; (22):218-49. PubMed ID: 30908
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of lipophilicity versus topological molecular descriptors in biological correlations.
    Basak SC; Harriss DK; Magnuson VR
    J Pharm Sci; 1984 Apr; 73(4):429-37. PubMed ID: 6726623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic control of breathing].
    Grassi V; Bruni B; Dottorini M; Malerba M; Tantucci C
    Recenti Prog Med; 1989; 80(7-8):404-16. PubMed ID: 2573117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of responses to drugs of abuse: an evaluation of research strategies.
    Shuster L
    NIDA Res Monogr; 1984; 54():50-69. PubMed ID: 6442763
    [No Abstract]   [Full Text] [Related]  

  • 18. QSAR: a critical appraisal.
    Archer S
    NIDA Res Monogr; 1978; (22):86-102. PubMed ID: 30914
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress with several models for the study of the SAR of hallucinogenic agents.
    Kier LB; Glennon RA
    NIDA Res Monogr; 1978; (22):159-85. PubMed ID: 101879
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure--activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water.
    Agresti A; Buffoni F; Kaufman JJ; Petrongolo C
    Mol Pharmacol; 1980 Nov; 18(3):461-7. PubMed ID: 7464812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.